Moderna is an American biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.
The US government recently signed a $ 1.5 billion agreement with the Moderna for Covid-19 vaccine. The Swiss government has also signed another agreement with the company.
Technically, the price has reached its trend line and a strong support level, and we can enter the position.
Summary of analysis and signal :
Active
Entry point: 69
stop-loss: 62
Take profit 1: 83
Take profit 2: 94